AMAG

AMAG NASDAQ
10.29
-0.40
-3.74%
Closed 16:29 08/22 EDT
Open
10.72
Prev Close
10.69
High
10.74
Low
10.17
Volume
1.29M
Avg Vol (3M)
1.24M
52 Week High
25.20
52 Week Low
6.81
% Turnover
3.81%
Market Cap
348.84M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers AMAG AMAG stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.
MORE >

Recently

Name
Price
%Change